Lifting the Hold on Applications: CIRM Proposes New Screening Plan for Clinical Research Awards
California enterprises, advanced trials would be favored, among other things
The California stem cell agency is moving to lift a hold on applications for multimillion-dollar clinical research awards and begin screening them using criteria that favor advanced clinical trials and California-based organizations over out-of-state enterprises.
The plan is aimed at dealing with a “tsunami” of applications that earlier this year overwhelmed the small staff of the California Institute for Regenerative Medicine(CIRM). The hold triggered concern from a number of researchers when it was imposed in February. It is scheduled to be lifted in June if the CIRM board approves the new plan late that month.
The criteria to be used are described as “objective” by the CIRM staff in a slide presentation. The full range of new criteria includes favoring:
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.